Efficacy of adjuvant chemotherapy according to hormone receptor status in young patients with breast cancer: a pooled analysis

被引：0
|
作者：
Jos A van der Hage
J Sven D Mieog
Marc J van de Vijver
Cornelis JH van de Velde
机构：
[1] Department of Surgery,Leiden University Medical Center
[2] European Organization for Research and Treatment of Cancer Data Center,The Netherlands Cancer Institute
[3] Department of Pathology,undefined
来源：
Breast Cancer Research | / 9卷
关键词：
Tamoxifen; Estrogen Receptor Status; Premenopausal Patient; LHRH Agonist; Adjuvant Systemic Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] High hormone receptor expression in breast cancer: Any need for adjuvant chemotherapy?
    Regierer, A. C.
    Wolters, R.
    Woeckel, A.
    Kurzeder, C.
    Novopashenny, I
    Kreienberg, R.
    Wischnewsky, M. B.
    ONKOLOGIE, 2010, 33 : 16 - 16
  • [22] Adjuvant chemotherapy in breast cancer patients with hormone-receptor-positive (responsive) disease: Focus on premenopausal patients
    Bergh, JCS
    ADVANCES IN ENDOCRINE THERAPY OF BREAST CANCER, PROCEEDINGS, 2004, : 127 - 136
  • [23] Benefit from adjuvant anthracyclines according to hormone receptor status
    Basaran, G. Atalay
    Cabuk, D.
    Teomete, M.
    Gulluoglu, B.
    Kaya, H.
    Dane, F.
    Yumuk, P. F.
    Turhal, N. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [24] Adjuvant chemotherapy in young women with breast cancer
    Álvaro Rodríguez-Lescure
    Breast Cancer Research and Treatment, 2010, 123 : 39 - 41
  • [25] Adjuvant chemotherapy in young women with breast cancer
    Rodriguez-Lescure, Alvaro
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 123 : 39 - 41
  • [26] Dyslipidaemias after adjuvant chemotherapy in young Chinese breast cancer patients
    Yeo, W.
    Mo, F.
    Suen, J.
    Loong, H.
    Pang, E.
    Yip, C.
    Liem, G. S.
    ANNALS OF ONCOLOGY, 2016, 27
  • [27] RISK OF SECOND BREAST CANCER ACCORDING TO HORMONE RECEPTOR STATUS IN GERMANY.
    Rusner, C.
    Wolf, K.
    Bandemer-Greulich, U.
    Holleczek, B.
    Schubert-Fritschle, G.
    Stang, A.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2012, 175 : S6 - S6
  • [28] Oncologic efficacy of gonadotropin-releasing hormone agonist in hormone receptor-positive very young breast cancer patients treated with neoadjuvant chemotherapy
    Choi, Hee Jun
    Lee, Jun Ho
    Jung, Chang Shin
    Ryu, Jai Min
    Chae, Byung Joo
    Lee, Se Kyung
    Yu, Jong Han
    Kim, Seok Won
    Nam, Seok Jin
    Lee, Jeong Eon
    Jung, Youn Joo
    Kim, Hyun Yul
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (27) : 6398 - 6406
  • [29] Oncology efficacy of gonadotropin-releasing hormone agonist in hormone receptor-positive very young breast cancer patients treated with neoadjuvant chemotherapy
    Choi, H. J.
    ANNALS OF ONCOLOGY, 2023, 34 : S287 - S287
  • [30] HER2 Status and Efficacy of Adjuvant Anthracyclines in Early Breast Cancer: a Pooled Analysis of Randomized Trials.
    Venkatraman, R.
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2008, 29 (02) : 28 - 29
12345